Advanced Filters
noise

Seol, Korea, Republic of Clinical Trials

A listing of Seol, Korea, Republic of clinical trials actively recruiting patients volunteers.

Found 1,034 clinical trials

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

19 - 80 years of age All Phase N/A

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

Enfortumab vedotin (or PADCEV Injection) is a treatment for cancer in the bladder lining (urothelial cancer). PADCEV Injection is now available to treat this cancer. People in this study will be adults in South Korea with locally advanced or metastatic urothelial cancer. Metastatic means the cancer has spread to other …

years of age All Phase N/A
H Hee Young Ju

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Aim of this study is to investigate the effect of early administration of anti-thymocyte globulin and post-transplant low-dose cyclophosphamide in heploidentical hematopoietic stem cell transplantation.

years of age All Phase N/A
J Joo Myung Lee, MD, MPH, PhD

Physiologic Assessment of Microvascular Function in Heart Transplant Patients

The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.

18 - 85 years of age All Phase N/A
S Seung hwan Moon, MD., Ph.D.

Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer

Hypothesis : imaging biomarkers of tumor measured by F-18 fluorodeoxyglucose (FDG) positron emission tomography(PET)/computed tomography(CT) is correlated with immune checkpoint inhibitor (ICI) treatment response and patient prognosis. Purpose: To evaluate the association between metabolic imaging parameters measured by F-18 FDG PET/CT and clinical outcomes in patients with non-small cell lung …

18 years of age All Phase N/A
H Hyo-Joon Yang, MD. PhD.

Cohort Study for Gastric MALT Lymphoma

The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls. Participants will be asked to provide clinical information and various tissues (saliva, gastric mucosa, and feces).

18 - 75 years of age All Phase N/A
M Minkyu Jung

A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer

Institutions will be selected This study aims to collect real-world data, targeting patients who started treatment with Enhertu from September 2022, for clinical data collection Among patients treated with Enhertu, those who have passed away or are no longer visiting due to hospice care will have their clinical data collected …

19 years of age All Phase N/A
s seohee Ko

Effect of Non-anemic Iron Deficiency on Outcome Following Off-pump Coronary Revascularization

This is a single center retrospective study of patients who underwent off pump coronary artery bypass surgery between 2016.11~2023.05. From this patient group, preoperatively non-anemic patients were selected and were divided into 2 cohorts according to their preoperative iron status; iron replete and iron deficient. These two cohorts were compared …

29 - 85 years of age All Phase N/A
E Elisabeth Kim

Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction

The goal of this observational study is to examine any clinical differences in the outcomes of breast reconstruction surgeries using Acellular Dermal Matrix (ADM) processed by CO2 supercritical fluid technology compared to other ADM products that have been washed with detergents. The study will also assess safety outcomes.

20 - 80 years of age Female Phase N/A

Registry Study on Rare Cancers in Korea

This study aims to determine the participation rate of patients with registered rare cancers in clinical research.

19 years of age All Phase N/A

Simplify language using AI